Willem L. Van Der Pol-Van Der Does

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 267 publications

READYCOM: protocol for a 2-year prospective natural history and cross-sectional muscle-fatigability study for improving trial readiness in congenital myopathies.

READYCOM: protocol for a 2-year prospective natural history and cross-sectional muscle-fatigability study for improving trial readiness in congenital myopathies.

Journal: BMJ open

Published: August 04, 2026

Lung Function and Respiratory Muscle Strength in Symptomatic Children and Adults With Spinal Muscular Atrophy Treated With Nusinersen.

Lung Function and Respiratory Muscle Strength in Symptomatic Children and Adults With Spinal Muscular Atrophy Treated With Nusinersen.

Journal: Neurology

Published: May 07, 2026

The Diagnostic Accuracy of the Second Revision of the European Academy of Neurology/Peripheral Nerve Society Guideline for Diagnosing Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

The Diagnostic Accuracy of the Second Revision of the European Academy of Neurology/Peripheral Nerve Society Guideline for Diagnosing Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Journal: European journal of neurology

Published: March 09, 2026

The SMN locus in the T2T era: Structure, gene conversion, and clinical implications.

The SMN locus in the T2T era: Structure, gene conversion, and clinical implications.

Journal: Trends in genetics : TIG

Published: January 30, 2026

Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Author Correction: Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial.

Journal: Nature medicine

Published: January 28, 2026

Motor function score changes in severe 5q spinal muscular atrophy during risdiplam treatment: an observational longitudinal nationwide cohort study.

Motor function score changes in severe 5q spinal muscular atrophy during risdiplam treatment: an observational longitudinal nationwide cohort study.

Journal: EClinicalMedicine

Published: January 20, 2026

Impaired renal function in patients with spinal muscular atrophy: A longitudinal cohort study.

Impaired renal function in patients with spinal muscular atrophy: A longitudinal cohort study.

Journal: Journal of neuromuscular diseases

Published: January 16, 2026

Temperature-induced symptoms in adolescents and adults with spinal muscular atrophy.

Temperature-induced symptoms in adolescents and adults with spinal muscular atrophy.

Journal: Journal of neuromuscular diseases

Published: December 19, 2025

A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy.

A plain language summary of the SAPPHIRE clinical trial of apitegromab in children and young adults with spinal muscular atrophy.

Journal: Expert review of neurotherapeutics

Published: November 13, 2025

IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy.

IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: November 12, 2025

CIDP With and Without Monoclonal Gammopathy of Undetermined Significance (MGUS): Comparison of Clinical Phenotype, Diagnostic Features, and Treatment Response.

CIDP With and Without Monoclonal Gammopathy of Undetermined Significance (MGUS): Comparison of Clinical Phenotype, Diagnostic Features, and Treatment Response.

Journal: Journal of the peripheral nervous system : JPNS

Published: September 12, 2025

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

Characterizing Combined Central and Peripheral Demyelination-Insights From a Multimodal Comparison With Chronic Inflammatory Demyelinating Polyneuropathy and Multiple Sclerosis.

Journal: Muscle & nerve

Published: August 01, 2025

Showing 1-12 of 267

Last Updated: 09/26/2026